25-Feb-2026 3:05 PM CST - Business Wire GoodRx Reports Fourth Quarter and Full Year 2025 Results GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," GoodRx, or the Company), the leading platform for medication savings in the U.S., has released its financial results for the fourth quarter and full year of 2025. Fourth Quarter 2025 Highlights Revenue of $194.8 million Net income of $5.4 million; Net income margin of 2.8% Adjusted Net Income1 of $29.0 million; Adjusted Net Income Margin1 of 14.9% Adjusted EBITDA1 of $65.0 million; Adjusted EBITD
28-Jan-2026 3:05 PM CST - Business Wire GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading platform for prescription savings in the U.S., today announced it will release its fourth quarter and full year 2025 financial results after U.S. markets close on Wednesday, February 25, 2026. GoodRx management will also hold a conference call and webcast the following morning, Thursday, February 26, 2026 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results a
16-Dec-2025 3:05 PM CST - Business Wire GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading platform for medication savings in the U.S., today announced that executives from the Company will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 13, 2026 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time), during which GoodRx will discuss business updates. A live webcast will be available on the Compan
4-Nov-2025 3:05 PM CST - Business Wire GoodRx Reports Third Quarter 2025 Results GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," GoodRx, or the Company), the leading platform for medication savings in the U.S., has released its financial results for the third quarter of 2025. Third Quarter 2025 Highlights Revenue of $196.0 million Net income of $1.1 million; Net income margin of 0.6% Adjusted Net Income1 of $28.8 million; Adjusted Net Income Margin1 of 14.7% Adjusted EBITDA1 of $66.3 million; Adjusted EBITDA Margin1 of 33.
8-Oct-2025 3:05 PM CST - Business Wire GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading platform for medication savings in the U.S., today announced it will release its third quarter 2025 financial results after U.S. markets close on Tuesday, November 4, 2025. GoodRx management will also hold a conference call and webcast the following morning, Wednesday, November 5, 2025 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Companys bus
6-Aug-2025 3:05 PM CST - Business Wire GoodRx Reports Second Quarter 2025 Results GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," GoodRx, or the Company), the leading platform for medication savings in the U.S., has released its financial results for the second quarter of 2025. Second Quarter 2025 Highlights Revenue of $203.1 million Net income of $12.8 million; Net income margin of 6.3% Adjusted Net Income1 of $33.9 million; Adjusted Net Income Margin1 of 16.7% Adjusted EBITDA1 of $69.4 million; Adjusted EBITDA Margin1 of
9-Jul-2025 3:05 PM CST - Business Wire GoodRx Announces Date for Second Quarter 2025 Earnings Release and Conference Call GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading platform for medication savings in the U.S., today announced it will release its second quarter 2025 financial results after U.S. markets close on Wednesday, August 6, 2025. GoodRx management will also hold a conference call and webcast the following morning, Thursday, August 7, 2025 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Companys busin
22-May-2025 8:00 AM CST - Business Wire GoodRx to Launch Direct Contracting for Independent Community Pharmacies GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that it will launch a new offering for independent community pharmacies - GoodRx Community Link - in June 2025. GoodRx Community Link will enable locally owned and operated pharmacies to directly contract with GoodRx on pricing and manage participation in the companys Integrated Savings Programs (ISP). Direct contracts leverage cost-plus models to provide indep
7-May-2025 3:13 PM CST - Business Wire GoodRx Reports First Quarter 2025 Results GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," GoodRx, or the Company), the leading platform for medication savings in the U.S., has released its financial results for the first quarter of 2025. First Quarter 2025 Highlights Revenue of $203.0 million Net income of $11.1 million; Net income margin of 5.4% Adjusted Net Income1 of $34.4 million; Adjusted Net Income Margin1 of 16.9% Adjusted EBITDA1 of $69.8 million; Adjusted EBITDA Margin1 of 34
25-Feb-2026 3:05 PM CST - Business Wire GoodRx Reports Fourth Quarter and Full Year 2025 Results GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," GoodRx, or the Company), the leading platform for medication savings in the U.S., has released its financial results for the fourth quarter and full year of 2025. Fourth Quarter 2025 Highlights Revenue of $194.8 million Net income of $5.4 million; Net income margin of 2.8% Adjusted Net Income1 of $29.0 million; Adjusted Net Income Margin1 of 14.9% Adjusted EBITDA1 of $65.0 million; Adjusted EBITD
28-Jan-2026 3:05 PM CST - Business Wire GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading platform for prescription savings in the U.S., today announced it will release its fourth quarter and full year 2025 financial results after U.S. markets close on Wednesday, February 25, 2026. GoodRx management will also hold a conference call and webcast the following morning, Thursday, February 26, 2026 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results a
16-Dec-2025 3:05 PM CST - Business Wire GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading platform for medication savings in the U.S., today announced that executives from the Company will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 13, 2026 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time), during which GoodRx will discuss business updates. A live webcast will be available on the Compan
4-Nov-2025 3:05 PM CST - Business Wire GoodRx Reports Third Quarter 2025 Results GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," GoodRx, or the Company), the leading platform for medication savings in the U.S., has released its financial results for the third quarter of 2025. Third Quarter 2025 Highlights Revenue of $196.0 million Net income of $1.1 million; Net income margin of 0.6% Adjusted Net Income1 of $28.8 million; Adjusted Net Income Margin1 of 14.7% Adjusted EBITDA1 of $66.3 million; Adjusted EBITDA Margin1 of 33.
8-Oct-2025 3:05 PM CST - Business Wire GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading platform for medication savings in the U.S., today announced it will release its third quarter 2025 financial results after U.S. markets close on Tuesday, November 4, 2025. GoodRx management will also hold a conference call and webcast the following morning, Wednesday, November 5, 2025 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Companys bus
6-Aug-2025 3:05 PM CST - Business Wire GoodRx Reports Second Quarter 2025 Results GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," GoodRx, or the Company), the leading platform for medication savings in the U.S., has released its financial results for the second quarter of 2025. Second Quarter 2025 Highlights Revenue of $203.1 million Net income of $12.8 million; Net income margin of 6.3% Adjusted Net Income1 of $33.9 million; Adjusted Net Income Margin1 of 16.7% Adjusted EBITDA1 of $69.4 million; Adjusted EBITDA Margin1 of
9-Jul-2025 3:05 PM CST - Business Wire GoodRx Announces Date for Second Quarter 2025 Earnings Release and Conference Call GoodRx Holdings, Inc. (Nasdaq: GDRX) (GoodRx or the Company), the leading platform for medication savings in the U.S., today announced it will release its second quarter 2025 financial results after U.S. markets close on Wednesday, August 6, 2025. GoodRx management will also hold a conference call and webcast the following morning, Thursday, August 7, 2025 at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Companys busin
22-May-2025 8:00 AM CST - Business Wire GoodRx to Launch Direct Contracting for Independent Community Pharmacies GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that it will launch a new offering for independent community pharmacies - GoodRx Community Link - in June 2025. GoodRx Community Link will enable locally owned and operated pharmacies to directly contract with GoodRx on pricing and manage participation in the companys Integrated Savings Programs (ISP). Direct contracts leverage cost-plus models to provide indep
7-May-2025 3:13 PM CST - Business Wire GoodRx Reports First Quarter 2025 Results GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," GoodRx, or the Company), the leading platform for medication savings in the U.S., has released its financial results for the first quarter of 2025. First Quarter 2025 Highlights Revenue of $203.0 million Net income of $11.1 million; Net income margin of 5.4% Adjusted Net Income1 of $34.4 million; Adjusted Net Income Margin1 of 16.9% Adjusted EBITDA1 of $69.8 million; Adjusted EBITDA Margin1 of 34
